deprivation significantly decreases (-30.5%) the thrombin generation potential in plasma evaluated upon extrinsic (TF/FVIIa pathway), but not intrinsic, activation of coagulation.
This variation was consistent with a decrease (-49.8%) in the plasma activity levels of factor VII (FVII), the crucial physiological trigger of coagulation, which was even more pronounced at the liver mRNA level (-85.7%). The recovery in normal sleep conditions for three days completely restored thrombin generation and FVII activity in plasma.
For the first time, we demonstrate that chronic sleep deprivation on its own reduces, in a reversible manner, the FVII expression levels, thus influencing the TF/FVIIa activation pathway efficiency.
INTRODUCTION
Chronic sleep debt affects millions of people in more developed countries and it is emerging as a co-factor in the development of metabolic and endocrine dysfunctions as well as of cardiovascular and cerebrovascular pathologies [1] [2] [3] [4] [5] . One of the well-characterized causes of partial chronic sleep deprivation (PSD), sleep apnea, has been clearly associated with cardiovascular disease [6] [7] [8] .
Among many factors, variations in the plasma levels of key proteins able to shift the haemostatic balance might contribute to the association between sleep deprivation and cardiovascular disorders. A number of studies have reported the association between levels of procoagulant (soluble Tissue Factor, fibrinogen, von Willebrand factor) and antifibrinolytic (Plasminogen activator inhibitor-1) molecules and sleep apnea. [9] [10] [11] [12] [13] [14] On the other hand, fragmentary information are available on the coagulant impact of sleep deprivation on its own. 15 In this paper, by exploiting the mouse model and a well established protocol to induce PSD 16 , we demonstrated that PSD strongly affects, in a reversible manner, the expression levels of factor VII (FVII), the serine-protease triggering the coagulation process. Experimental design. Mice (N=18) underwent 20-hrs of sleep deprivation using a slowly rotating wheel (1.0 r.p.m. x 20 hrs/day = 1200 total wheels revolution/day), after which they were transferred to their home cage for a 4-h sleep opportunity in the first part of the light phase from ZT0 to ZT4. Mice were subdivided in 3 groups (N=6 each group) and subjected to 3 days of sleep deprivation, 7 days of sleep deprivation or 7 days of sleep deprivation followed by a recovery in normal condition for 3 days. Non-sleep deprived mice (N=18, 6 for each sleep deprived group) were placed in a non-rotating wheel for 20-h/day and in a home cage for 4-h/day to exert experimental control over the recording environments.
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DESIGN AND METHODS
A second group of mice (N=8) was exploited to investigate the effect of forced activity on coagulation. A group (N=4) was subjected for 7 days to forced activity (1.7 r.p.m.) for 12
hrs/day from ZT12 to ZT24. This daily amount of activity was equivalent to the amount of activity performed by mice subjected to PSD (1224 wheels revolution/day). Mice were subsequently transferred to their home cage for a 12-h sleep opportunity during the light phase (from ZT0 to ZT12). The control mice (N=4) were housed for 7 days in a nonrotating wheel for 12-h/day and in a home cage for 12-h/day.
The last day of treatment, at ZT0, all experimental and control mice were anesthetized with isoflurine and subjected to retro-orbital bleeding to isolate plasma, and then sacrificed to isolate livers, as previously described. 18 Mice subjected to sleep deprivation show a modest reduction in weight (about 2-3% after 3 days and about 5-6 % after 7 days of PSD). The mice regained most of the weight loss Functional assays in plasma. Thrombin generation assays, optimized to evaluate the efficiency of the extrinsic or the intrinsic activation coagulation pathways, as well as the FVII activity assays were conducted in mouse plasma as previously described.
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Student's t-test was used to determine significant differences (p<0.05).
q-PCR. DNase-treated total RNA was isolated from mouse liver using Trizol reagent (Invitrogen, Carlsbad, CA) and used to perform cDNA synthesis (iScriptTM cDNA synthesis kit, Biorad, Milan, Italy). cDNA was PCR-amplified with a Chromo4 Real-Time PCR Detection System using iQTM SYBR Green Supermix (Biorad, Milan, Italy). Primers for mouse FVII mRNA quantifications were 5'-GACTTTGACGGTCGGAACTGTG-3' and 5'-GCGGCTGCTGGAGTTTCTTT-3'. Mouse GAPDH (5'-AACTTTGGCATTGTGGAAGG-3' and 5'-ACACATTGGGGGTAGGAACA-3') was used as housekeeping gene. The comparable amplification efficiencies of FVII and GAPDH transcripts prompted us to exploit the comparative threshold cycle method (CT), as previously described. 18 Each CT value used for these calculations is the mean of three replicates of the same reaction.
One-way ANOVA was used to determine significant differences (p<0.05) and the Dunnett's post-hoc test was applied to compare experimental groups with the control group.
RESULTS AND DISCUSSION
We have previously shown that the circadian clock plays an important role in the modulation of the coagulation cascade efficiency, mainly by modulating the TF/FVIIa pathway. [18] [19] [20] [21] Since sleep and wake cycles and the circadian system closely interact with each other, we investigated whether PSD has any effect on the thrombin generation activity in plasma, a parameter defining the coagulation cascade efficiency. 22 To this purpose we exploited the mouse model and a recently developed PSD protocol. 16 This is a very effective method to induce PSD in rodents and although micro-sleep events In mice subjected to 3 days of PSD we did not observe a statistically significant variation of thrombin generation activity levels in plasma, neither upon extrinsic nor intrinsic activation of coagulation (Figure 1A -B; p>0.1 and p>0.4, respectively). When the PSD period was prolonged to 7 days, we detected a significant reduction (-30.5 %; p<0.01) of thrombin generation activity levels upon extrinsic activation ( Figure 1D ). Conversely, upon intrinsic activation, these levels were comparable to those of control mice ( Figure 1E ).
To corroborate these findings we monitored the thrombin generation activity upon extrinsic trigger in the PSD mice after 3 days of undisturbed sleep, and found that it returned to be undistinguishable from that of controls (Figure 1G -I; p>0.1).
These data indicate that PSD significantly affects, in a reversible manner, the efficiency of the extrinsic activation pathway, characterized by the activity of the TF/FVIIa complex.
Since in our functional assay TF is added in excess to mouse plasma, the variation of FVII activity levels likely explains the observed phenomenon. Other features of FVII support our mechanistic hypothesis: i) FVII has a very-short half life (2-4 h), thus permitting quick level fluctuations over time, and ii) FVII gene expression is directly controlled by the circadian clock machinery 18 , which is strongly interlaced with the sleep/wake mechanisms.
In accordance with this hypothesis, the activity levels of FVII in plasma from mice subjected to 3 and 7 days of PSD were reduced of 29.2% ( Figure 1C , p<0.001) and 49.8%
( Figure 1F , p<0.001) when compared to controls, respectively. Furthermore, 3 days of undisturbed sleep was able to completely restore FVII activity levels ( Figure 1I ; p>0.1), in line with the short half-life of this factor.
To corroborate this finding and to provide insights into the regulation at the transcriptional level, we investigated FVII gene expression in liver mRNA previously isolated from PSD mice ( Figure 2 ). We observed a clear relationship between PSD conditions and a DOI: 10.3324/haematol.2010.022475 reduction in FVII mRNA levels in liver, particularly after 7 days (-85.7%, p<0.01). As observed for FVII activity, the normal FVII mRNA expression was restored by a 3 days of undisturbed sleep.
One might argue that the variations reported here are due to increased levels of physical activity rather than the lack of sleep. To address this concern we investigated the effect of forced activity on thrombin generation and FVII activity levels. The forced activity (12 hrs/day from ZT12 to ZT24 for seven days) did not result in a significant change in any of the parameters under investigation (Figure 3 A-D, p>0 .1 in all cases), thus strengthening our main findings on the effects of PSD.
Very recently Liu and colleagues 15 suggested that a 1-day sleep deprivation results in a slight shortening of coagulation times (PT, APTT) in ten healthy humans. Other studies, mainly focused on sleep apnea patients, reported a positive association between daily sleep disturbance/reduction and levels of specific prothrombotic factors (i.e. soluble Tissue Factor, von Willebrand factor, fibrinogen) [9] [10] [12] [13] [14] 23 , thus supporting a relationship between sleep deprivation and cardiovascular risk. Our data poorly fit this hypothesis and would rather support a counteracting mechanism. It is tentative to speculate that the reduction of FVII levels may concur to the haemostatic balance through compensatory mechanisms operating in the coagulation/haemostasis pathways. A similar mechanism has been suggested by the parallel temporal oscillations in levels of FVII, and of its direct inhibitor tissue factor pathway inhibitor. 19 Further studies aimed at evaluating the impact of sleep deprivation on plasma levels of a wide panel of coagulation and fibrinolytic factors are needed to address the physiopathology of this complex pathway.
For the first time, through the use of a well controlled animal model and a specifically designed experimental protocol, we demonstrated that chronic sleep deprivation on its own strongly affects and reduces, in a reversible fashion, the expression levels of FVII, 
